Cancer Immunotherapy Using Bioengineered Micro/Nano Structured Hydrogels
Advanced Healthcare Materials · 2023-10 · 12 (27)
DOI: 10.1002/adhm.202301174 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2023-09. Verfasst von Esfandyar Askari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Innovations in Micro Engineering (LiME), Department of Mechanical Engineering, University of Victoria, Victoria, BC V8P 5C2, Canada. Hauptthemen laut MEDLINE: Hydrogels, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Hydrogels, a class of materials with a 3D network structure, are widely used in various applications of therapeutic delivery, particularly cancer therapy. Micro and nanogels as miniaturized structures of the bioengineered hydrogels may provide extensive benefits over the common hydrogels in encapsulation and controlled release of small molecular drugs, macromolecular therapeutics, and even cells. Cancer immunotherapy is rapidly developing, and micro/nanostructured hydrogels have gained wide attention regarding their engineered payload release properties that enhance systemic anticancer immunity. Additionally, they are a great candidate due to their local administration properties with a focus on local immune cell manipulation in favor of active and passive immunotherapies. Although applied locally, such micro/nanostructured can also activate systemic antitumor immune responses by releasing nanovaccines safely and effectively inhibiting tumor metastasis and recurrence. However, such hydrogels are mostly used as locally administered carriers to stimulate the immune cells by releasing tumor lysate, drugs, or nanovaccines. In this review, the latest developments in cancer immunotherapy are summarized using micro/nanostructured hydrogels with a particular emphasis on their function depending on the administration route. Moreover, the potential for clinical translation of these hydrogel‐based cancer immunotherapies is also discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Innovations in Micro Engineering (LiME), Department of Mechanical Engineering, University of Victoria, Victoria, BC V8P 5C2, Canada.
- Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, 1449614535, Iran.
- ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, 1517964311, Iran.
- Biomaterials and Tissue Engineering Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, 1517964311, Iran.
- Center for Advanced Materials and Related Technologies, University of Victoria, Victoria, BC V8P 5C2, Canada.
- Center for Biomedical Research, University of Victoria, Victoria, BC V8P 5C2, Canada.
ORCID-Profile: Mohsen Akbari
Zitieren
APA
Askari, E., Shokrollahi Barough, M., Rahmanian, M., Mojtabavi, N., Sarrami Forooshani, R., Seyfoori, A., & Akbari, M. (2023). Cancer Immunotherapy Using Bioengineered Micro/Nano Structured Hydrogels. Advanced Healthcare Materials, 12(27). https://doi.org/10.1002/adhm.202301174
Vancouver
Askari E, Shokrollahi Barough M, Rahmanian M, Mojtabavi N, Sarrami Forooshani R, Seyfoori A, et al. Cancer Immunotherapy Using Bioengineered Micro/Nano Structured Hydrogels. Advanced Healthcare Materials. 2023;12(27). doi:10.1002/adhm.202301174
BibTeX
@article{Askari2023,
author = {Askari, Esfandyar and Shokrollahi Barough, Mahdieh and Rahmanian, Mehdi and Mojtabavi, Nazanin and Sarrami Forooshani, Ramin and Seyfoori, Amir and Akbari, Mohsen},
title = {Cancer Immunotherapy Using Bioengineered Micro/Nano Structured Hydrogels},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {27},
doi = {10.1002/adhm.202301174}
}
EUVIMED